Ulipristal Acetate
1 NDC across 1 manufacturer|0 Generic,1 Brand
▸ More about this market▾ Less
The brand product was first FDA-approved on Aug 13, 2010, and the first generic was approved Feb 13, 2017. FDA's Orange Book lists 2 AB-rated (therapeutically equivalent) products for this ingredient.
Ulipristal Acetate is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $37.10 to $37.10 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$37.10 – $37.10
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing ULIPRISTAL ACETATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ELLA 30 MG TABLET | $37.1002 per EA | +0.02% |
Frequently Asked Questions
When did Ulipristal Acetate become available as a generic?
FDA approved the first generic Ulipristal Acetate (ANDA) on Feb 13, 2017. The Orange Book currently lists 2 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Ulipristal Acetate products are on the market?
The Ulipristal Acetate drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Ulipristal Acetate?
NADAC reference prices for Ulipristal Acetate range from $37.1002 to $37.1002 per EA.
Which manufacturers make Ulipristal Acetate?
1 manufacturer lists Ulipristal Acetate in NADAC. Ranked by number of NDCs, the largest are HRA PHARMA AMERICA, INC. (1).
How has the price of Ulipristal Acetate changed recently?
Over the past 7 days, 1 Ulipristal Acetate NDC rose and 0 fell, with a market-wide average change of +0.0%.